Clinical Trials
3 trialsNCT00364780 2022-05-13
Study of XL647 in Subjects With Non-Small-Cell Lung Cancer
Kadmon Corporation, LLC
Phase 2 Completed
NCT00522145 2022-05-13
Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib
Kadmon Corporation, LLC
Phase 2 Completed
NCT02616393 2022-03-16
Phase 2 Study of Study of Tesevatinib in Subjects With NSCLC and Brain or Leptomeningeal Metastases
Kadmon Corporation, LLC
Phase 2 Completed